Novavax (NVAX) Intangibles (2013 - 2022)
Novavax's (NVAX) quarterly Intangibles came in at $8.5 million in Q3 2022, up 68.21% year-on-year from $5.0 million in Q3 2021, and up 109.67% quarter-over-quarter from $4.0 million in Q2 2022.
Novavax (NVAX) Intangibles (2013 - 2022) Analysis & Trends
Novavax's Intangibles history runs 10 years deep, the most recent figure standing at $8.5 million for Q3 2022.
- On a quarterly basis, Intangibles rose 68.21% year-over-year to $8.5 million in Q3 2022; TTM through Sep 2022 was $8.5 million, a 68.21% increase from a year earlier, with the FY2021 full-year figure at $4.8 million, down 16.68% from the prior year.
- Intangibles grew to $8.5 million in Q3 2022 per NVAX's latest filing, from $4.0 million in the prior quarter.
- Across five years, Intangibles topped out at $8.5 million in Q3 2022 and bottomed at $4.0 million in Q2 2022.
- The 5-year median for Intangibles is $5.5 million (2019), against an average of $5.8 million.
- Across the five-year window, Intangibles slipped 27.21% in 2018 and jumped 68.21% in 2022, its largest moves.
- Year by year, Intangibles stood at $6.5 million in 2018, then declined by 14.68% to $5.6 million in 2019, then rose by 2.58% to $5.7 million in 2020, then dropped by 16.68% to $4.8 million in 2021, then jumped by 77.27% to $8.5 million in 2022.
- Per Business Quant, the three latest NVAX Intangibles figures stand at $8.5 million (Q3 2022), $4.0 million (Q2 2022), and $4.5 million (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 8.46 Mn |
| Jun 30, 2022 | 4.03 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 5.28 Mn |
| Mar 31, 2021 | 5.27 Mn |
| Dec 31, 2020 | 5.73 Mn |
| Sep 30, 2020 | 5.33 Mn |
| Jun 30, 2020 | 5.25 Mn |
| Mar 31, 2020 | 5.05 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Sep 30, 2019 | 5.47 Mn |
| Jun 30, 2019 | 5.96 Mn |
| Mar 31, 2019 | 6.11 Mn |
| Dec 31, 2018 | 6.54 Mn |
| Sep 30, 2018 | 6.75 Mn |
| Jun 30, 2018 | 6.90 Mn |
| Mar 31, 2018 | 7.58 Mn |
| Dec 31, 2017 | 7.87 Mn |